151 related articles for article (PubMed ID: 7909722)
1. Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
Hegen M; Camerini D; Fleischer B
Cell Immunol; 1993 Feb; 146(2):249-60. PubMed ID: 7909722
[TBL] [Abstract][Full Text] [Related]
2. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.
Hegen M; Niedobitek G; Klein CE; Stein H; Fleischer B
J Immunol; 1990 Apr; 144(8):2908-14. PubMed ID: 1969875
[TBL] [Abstract][Full Text] [Related]
3. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells.
Hegen M; Mittrücker HW; Hug R; Demuth HU; Neubert K; Barth A; Fleischer B
Immunobiology; 1993 Dec; 189(5):483-93. PubMed ID: 7907318
[TBL] [Abstract][Full Text] [Related]
5. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.
Bednarczyk JL; Carroll SM; Marin C; McIntyre BW
J Cell Biochem; 1991 Jul; 46(3):206-18. PubMed ID: 1723066
[TBL] [Abstract][Full Text] [Related]
6. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional expression of the T cell activation antigen CD26.
Tanaka T; Camerini D; Seed B; Torimoto Y; Dang NH; Kameoka J; Dahlberg HN; Schlossman SF; Morimoto C
J Immunol; 1992 Jul; 149(2):481-6. PubMed ID: 1352530
[TBL] [Abstract][Full Text] [Related]
8. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
[TBL] [Abstract][Full Text] [Related]
9. Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity.
Steeg C; Hartwig U; Fleischer B
Cell Immunol; 1995 Sep; 164(2):311-5. PubMed ID: 7656337
[TBL] [Abstract][Full Text] [Related]
10. A novel pathway of human T cell activation via a 103 kD T cell activation antigen.
Fleischer B
J Immunol; 1987 Mar; 138(5):1346-50. PubMed ID: 3100637
[TBL] [Abstract][Full Text] [Related]
11. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
[TBL] [Abstract][Full Text] [Related]
12. Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex.
Fleischer B; Sturm E; De Vries JE; Spits H
J Immunol; 1988 Aug; 141(4):1103-7. PubMed ID: 2840462
[TBL] [Abstract][Full Text] [Related]
13. The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD26.
Mittrücker HW; Steeg C; Malissen B; Fleischer B
Eur J Immunol; 1995 Jan; 25(1):295-7. PubMed ID: 7843246
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.
Subramanyam M; Gutheil WG; Bachovchin WW; Huber BT
J Immunol; 1993 Mar; 150(6):2544-53. PubMed ID: 8095514
[TBL] [Abstract][Full Text] [Related]
15. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
16. Purified and cell-bound CD26: enzymatic inhibition, antibody binding profile, and expression on T cells in relation to other surface markers.
Scharpe S; De Meester I
Verh K Acad Geneeskd Belg; 1994; 56(6):537-59. PubMed ID: 7892748
[TBL] [Abstract][Full Text] [Related]
17. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells.
Gaetaniello L; Fiore M; de Filippo S; Pozzi N; Tamasi S; Pignata C
Hepatology; 1998 Apr; 27(4):934-42. PubMed ID: 9537431
[TBL] [Abstract][Full Text] [Related]
18. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
[TBL] [Abstract][Full Text] [Related]
19. Thymocyte costimulating antigen is CD26 (dipeptidyl-peptidase IV). Costimulation of granulocyte, macrophage, and T lineage cell proliferation via CD26.
Bristol LA; Sakaguchi K; Appella E; Doyle D; Takács L
J Immunol; 1992 Jul; 149(2):367-72. PubMed ID: 1352525
[TBL] [Abstract][Full Text] [Related]
20. T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukaemic cells.
Claesson MH; Dissing S; Tscherning T; Geisler C
Immunology; 1993 Mar; 78(3):444-8. PubMed ID: 8097490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
